- 询价
- Signalway Antibody
- 48042
- 2025年09月23日
- WB, ICC, IHC, FC
- Rabbit
- Human;Mouse
企业认证
相关产品推荐更多 >
![PKC gamma Conjugated Antibody[C49912]](https://img1.dxycdn.com/p/s14/2025/0923/305/2150219664296040791.jpg!wh200)
![BOB1 Rabbit mAb[56535]](https://img1.dxycdn.com/p/s14/2025/0922/632/2321321568067599691.jpg!wh200)
![MKRN2 Antibody[SAB483]](https://img1.dxycdn.com/p/s14/2025/0922/498/0460884283108299691.jpg!wh200)
![Endoplasmic reticulum resident protein 29 Polyclonal Antibody[42431]](https://img1.dxycdn.com/p/s14/2025/0922/568/0046652811090600791.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
recombinant protein
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Polyclonal
- 适应物种：
Human;Mouse
- 保质期：
12 months
- 抗原来源：
Rabbit
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
WB, ICC, IHC, FC
- 靶点：
Uniprot：P43146
- 抗体英文名：
Netrin receptor DCC Antibody
- 规格：
50ul/100ul
Colorectal cancer suppressor antibody
CRC 18 antibody
CRC18 antibody
CRCR 1 antibody
CRCR1 antibody
DCC antibody
DCC_HUMAN antibody
Deleted in colorectal cancer protein antibody
Deleted in colorectal carcinoma antibody
Immunoglobulin superfamily DCC subclass member 1 antibody
Netrin receptor DCC antibody
Tumor suppressor protein DCC antibody
计算分子量:90 kDa
配方:1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
应用详情:WB: 1:500-1:1,000
图片:
Western blot analysis on Hela using anti- Netrin receptor DCC polyclonal antibody
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Aspects of CNS Lupus: Mouse Models of Anti-NMDA Receptor Antibody Mediated Reactivity
This chapter describes methods utilized in establishing a mouse model of neuropsychiatric lupus encompassing both cognitive and emotional dysfunction, and a model of the influence of maternal antibody on the developing brain. The antibody
This work describes protocols for the production of single-chain antibody and T-cell receptor fragments inE. coli . A choice of methods is given for the purification of the recombinant fragments that rely on the use of either immunoaffinity
Antibody Targeted siRNA Delivery
only. The commercial success of in vivo applications of RNAi hinges on the development of new delivery methods. Our strategy involves the use of antibody-based delivery agents to target and deliver siRNA into specific cell types. We have developed antibody-based agents
技术资料暂无技术资料 索取技术资料
